INDICATIONS AND USAGE Erlotinib is a kinase inhibitor indicated for: · The treatment of patients with metastatic…
INDICATIONS AND USAGE Dacomitinib is a kinase inhibitor indicated for the first-line treatment of patients with…
About Belzutifan Belzutifan is an hypoxia-inducible factor-2 alpha inhibitor. Belzutifan is used to treat von Hippel-Lindau…
Selumetinib is a prescription medicine that is used to treat children 2 years of age and…
TYVYT® (sintilimab injection) is a fully human IgG4 monoclonal antibody, which specifically binds to PD-1 expressed on…
About Savolitinib Savolitinib is an oral, potent, and highly selective MET TKI that has demonstrated clinical…
About Furmonertinib Furmonertinib Mesilate acts as an anti-cancer agent. It is formulated as tablets for oral…
About Pyrotinib Irene (Pyrotinib) sold under the brand name 艾瑞妮 in china, Pyrotinib is an irreversible dual…
About Febuxostat Febuxostat is used to lower hyperuricemia (high uric acid in the blood) in patients…
About Apalutamide Apalutamide is a nonsteroidal antiandrogen medication used for the treatment of prostate cancer. It…
About Tepotinib Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping…
About Olaparib Olaparib is a poly (ADP ribose) polymerase (PARP) inhibitor, at least before monotherapy Germline…
About Fruquintinib Fruquintinib (Fruzaqla) sold under the brand name 爱优特 in china, is an oral, highly selective,…
About Adagrasib Adagrasib is a prescription medicine used in adults: alone to treat non-small cell lung…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
About Pralsetinib Pralsetinib is a tyrosine kinase inhibitor. It is taken by mouth. Pralsetinib is a medication approved for RET mutation-positive medullary…
Copyright © 2021-2022 LienTeh.net All rights reserved.
